Most Short Children with Cystic Fibrosis Do Not Catch Up by Adulthood

Margaret P Marks1,2, Sonya L Heltshe3,4, Arthur Baines4

  • 1Department of Pediatrics, University of Alabama, Birmingham, AL 35233, USA.

Nutrients
|December 28, 2021
PubMed

Insights

Poor linear growth in children with cystic fibrosis (CF) is linked to shorter adult height. Early childhood growth assessment can predict adult height outcomes in CF patients.

Area of Science:

  • Pediatrics
  • Genetics and Genomics
  • Endocrinology

Background:

  • Poor linear growth is a common complication in children with cystic fibrosis (CF), often preceding pulmonary decline.
  • Growth impairment in CF develops early in life, even with intensive nutritional interventions.

Purpose of the Study:

  • To investigate the association between early childhood growth restriction and adult height in individuals with cystic fibrosis.
  • To determine if early height for age (HFA) percentiles in CF children predict their adult stature.

Main Methods:

  • Utilized the Cystic Fibrosis Foundation (CFF) patient registry to identify 3655 CF adults (ages 18-19) with HFA records from ages 2-4.
  • Analyzed the correlation between early childhood HFA and adult height percentiles.

Main Results:

  • Only 26% of CF adults were at or above the median HFA, and 25% were below the 10th percentile.
  • Children with CF below the 10th percentile HFA at ages 2-4 had a 7.7-fold increased odds of being below the 10th percentile as adults.
  • A significant proportion (58%) of CF individuals with HFA between the 10th and 25th percentiles at ages 2-4 remained below the 25th percentile in adulthood.

Conclusions:

  • Low early childhood height in cystic fibrosis patients is strongly correlated with reduced adult height.
  • Early growth assessment in CF is crucial for predicting adult stature and may inform interventions to improve long-term health outcomes, including pulmonary status.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
390
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
238
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
21.0K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
720
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
20